Serzone Antidepressant

Very few patients and doctors take the time to read FDA issued label changes warning of serious and deadly Serzone antidepressant side effects that can occur. Despite a Black Box warning being the strongest FDA warning issued, many doctors even admit not knowing the last time they have seen a Serzone antidepressant drug label. While the FDA has been criticized for not being proactive enough when issuing warnings of possible death and serious side effects, a patient should take responsibility for reading their patient packet inserts and Serzone antidepressant drug labels.

While these informational pamphlets are often hard to read with the fine print and loaded drug information, by educating yourself about the dangers and risks of Serzone antidepressant drug, as well as possible complications to be aware of, you can help prevent death or serious injury from occurring.

 

Serzone Antidepressant Risks

Adverse drug reactions account for about 100,000 deaths in the U.S. every year, making it the fourth-leading cause of death overall. Serzone antidepressant drug, FDA approved in 1994, is contributing to the prescription drug death statistic due to the cases of liver failure that have resulted from its use. The rate of liver failure associated to Serzone antidepressant drug is approximately three to four times greater than an individual not treated with Serzone antidepressant. A report that was published in the Wall Street Journal identified that one person in 250,000 to 300,000 taking Serzone antidepressant will suffer a liver failure.

So far, an estimated 7 million Americans have taken Serzone antidepressant drug. While the amount of Americans that suffer from depression has experienced a dramatic increase, Dr. Andrew Stanway, a British physician, says "If antidepressant drugs were really as effective as they are made out to be, surely hospital admission rates for depression would have fallen over the twenty years they've been available."
FDA Issues Sezone Antidepressant
Black Box Warning
The FDA has finally responded to the reported 109 serious liver damage cases caused by Serzone antidepressant by notifying Serzone manufacturer Bristol-Myers on December 7, 2001 that they needed to add a Black Box warning on the label and provide new patient inserts to Serzone antidepressant drug users. A Black Box warning is the strongest type of warning that the FDA issues. In January the FDA again revised the information on the Serzone antidepressant label.

Life-Threatening Hepatic Failures Reported in Patients Treated With Serzone Antidepressant
The number of adverse Serzone antidepressant side effects is thought grossly underestimated due to underreporting. The FDA's efforts to warn users of Serzone antidepressant drug of the "cases of life-threatening hepatic failure have been reported in patients treated with Serzone" follow the Canadian government's action by six months. Canada was the first country to take note of the risk of experiencing a liver failure when taking Serzone antidepressant and immediately had Bristol-Myers send letters notifying doctors of the risk of developing a Serzone liver damage problem. At this time Bristol-Myers failed to notify any American doctors of the antidepressant and when asked about this matter a spokeswoman said, "We didn't think it was necessary in the U.S. because what happened in Canada was specific to Canada."
Every consumer has the right to receive all the information that the company is aware of or violations have been committed. Our site has been created to make individuals aware of the dangers associated to prescription drugs and the company's responsibility to provide full disclosure to the doctors and consumers. Many people believe that once a drug receives FDA approval it is free of risk. The fact remains that prescription drug complications continue to kill unknowing individuals at a very high rate.


View the Full Revised Serzone Antidepressant Label
View the Serzone Patient Packet Insert


Serzone Antidepressant Causes Liver Damage

Figures are probably more conservative than the actual number of liver complications that have arisen due to Serzone antidepressant drug because of underreporting . . .

About Serzone Antidepressant Drug

Consumer advocacy group, Public Citizen, has provided comprehensive information on Serzone antidepressant drug. The Serzone information includes how to administer the antidepressant and possible adverse effects to be aware of . . .

Safer Antidepressant Drug Use

By taking the time to learn about the antidepressant medication that your doctor wishes to administer you can help avoid injuries that have led to instances like the Serzone liver failures . . .

 



Dangers of Serzone Antidepressant
The type of liver damage Serzone antidepressant drug can cause ranges from asymptomatic reversible increases in serum transaminase to serious cases of liver failure. Liver damage that leads to instances of liver failure resulting in transplant and/or death has been associated to the use of Serzone antidepressant.
What is a Black Box Warning?
The FDA issues Black Box warnings when a drug is associated to a high risk of serious and deadly side effects. This type of warning is the strongest warning possible. Serzone manufacturer, Bristol-Myers, was told in December 2001 that their antidepressant drug must include a Black Box to warn patients of the "life-threatening hepatic failure" that had been reported. The "black box" refers to the thick black outline that surrounds the warning.
 
 
 
Serzone Antidepressant Risks